7 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 7 of 7 clinical reviews.
A clinical-level review of copper peptide pharmacology, adverse-event profiles, and management protocols for prescribers and dispensers. Covers GHK-Cu, dosing thresholds, skin and systemic reactions, and monitoring frameworks.
A prescriber-level guide to copper peptide drug class pharmacology, compounding regulations, billing codes, and prior-authorization strategy for GHK-Cu and related peptides.
A prescriber-level monograph covering the copper peptides drug class: mechanisms, pharmacology, clinical evidence, dosing, safety, and comparisons with prototype GHK-Cu. Includes citations to primary literature.
Complete drug-drug interaction (DDI) table for the copper peptides class, centered on GHK-Cu. Covers topical and systemic formulations, chelation conflicts, retinoid co-use, and monitoring guidance for polypharmacy patients.
Evidence-based monitoring protocol for copper peptide (GHK-Cu) therapy covering baseline labs, ongoing surveillance intervals, serum copper and ceruloplasmin targets, hepatic panels, and discontinuation criteria for prescribing clinicians.
A clinical-level review of copper peptide pharmacology, dosing, and safety across special populations including pregnancy, pediatrics, renal impairment, and older adults. Written for prescribers and dispensing clinicians.
A physician-level guide to copper peptide pharmacology, GHK-Cu dosing protocols, titration schedules, tapering strategies, and safety monitoring for skin and hair regeneration.